Cassia Cearley - 07 Mar 2022 Form 4 Insider Report for Icosavax, Inc.

Role
Chief Business Officer
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact for Cassia Cearley
Issuer symbol
N/A
Transactions as of
07 Mar 2022
Net transactions value
-$171,629
Form type
4
Filing time
09 Mar 2022, 16:34:11 UTC
Previous filing
14 Feb 2022
Next filing
22 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Sale $163,009 -9,516 -8.8% $17.13 98,897 07 Mar 2022 Direct F1, F2
transaction ICVX Common Stock Sale $8,620 -484 -0.49% $17.81 98,413 07 Mar 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.71 and $17.63. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
F3 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.78 and $17.88. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.